Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD
Abstract Inhaled bronchodilators are central for the treatment of chronic obstructive pulmonary disease (COPD), as they can provide symptom relief and reduce the frequency and severity of exacerbations while improving health status and exercise tolerance. In 2017, glycopyrrolate (GLY) delivered via...
Enregistré dans:
Auteurs principaux: | , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/34def7afb7e54f30b071260caa02f52c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|